Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Massive study reports challenges in reproducing published psychology findings

  • Four-day school week can improve academic performance, study finds

  • Cannabis and the brain

  • Awareness of memory loss may decline two-three years before dementia onset

  • 'Brainbow' reveals surprising data about visual connections in brain

  • To get girls more interested in computer science, make classrooms less 'geeky'

  • About 10 percent of mothers experienced depression two years after Hurricane Katrina

  • Alzheimer?s disease thought to be accelerated by an abnormal build-up of fat in the brain

  • Parkinson?s disease brain cells at risk of burnout, like an overheating motor

  • Creative and neurotic: Is neuroticism fueled by overthinking?

  •